-
BioMarin (BMRN) Jumps 17.7% on $5-Billion Merger with Amicus
20 Dec 2025 19:09 GMT
We recently published 10 Firms in the Limelight. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best performers on Friday. BioMarin Pharmaceutical extended its winning streak to a third straight day on Friday, surging 17.71 percent to finish at $ …
-
Amicus (FOLD) Flies to 52-Week High on $5-Billion BioMarin Merger
20 Dec 2025 19:10 GMT
We recently published 10 Firms in the Limelight. Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best performers on Friday. Amicus Therapeutics soared to a new 52-week high on Friday, jumping 30.21 percent to close at $14.18 apiece as investors …
-
Mergers and Acquisitions — Reviewing 2025 and Looking Ahead to 2026
20 Dec 2025 14:55 GMT
… may come in 2026.
* * *
Mega Mergers Reemerge. This year has witnessed … Bros., Teck Resources’ $69 billion merger of equals with Anglo American … the prevalence of CVRs in pharmaceutical and biotech M&A …
-
BioMarin makes its largest-ever transaction, paying $4.8B for fellow rare disease drugmaker Amicus
19 Dec 2025 18:29 GMT
… 28-year history.
In a merger of rare disease specialists, BioMarin … soon face competition from Ascendis Pharma';s TransCon CNP, which … of the year after the drugmaker gained Inozyme for $270 million …
-
Fierce Pharma Asia—Daiichi ADCs' 1st-line nod, trial deaths; Takeda's TYK2 trial win
19 Dec 2025 18:29 GMT
… clinical hold comes as the pharma partners said they were aiming … Alzheimer's med
Fosun Pharma is spending about $200 million … 53% stake in Green Valley Pharmaceuticals, aiming to revive the latter … to go public in reverse merger with Vyne (release)
12. …
-
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
19 Dec 2025 12:00 GMT
… regarding a proposed reverse merger transaction pursuant to which … testing solutions.
CDL Pharma provides clinical trial logistics … obligations of the post-merger entity. Transaction Status
… including ABL Diagnostics, CDL Pharma, and Humedics, delivering …
-
Advanced Biological Laboratories Signs Non-Binding LOI for Proposed Reverse Merger with ProPhase Labs
19 Dec 2025 07:00 GMT
… regarding a proposed reverse merger transaction pursuant to which … Following completion of the merger, a newly established U … testing solutions.
- CDL Pharma provides clinical trial logistics … obligations of the post-merger entity.
Transaction Status
The …
-
<![CDATA[Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release]]>
19 Dec 2025 00:25 GMT
… .
In today’s Pharmaceutical Executive Daily, Pfizer … new collaboration and merger activity highlights continued … downstream access considerations for pharmaceutical manufacturers.
In deal news … Thanks for listening to Pharmaceutical Executive Daily. For …
-
Dow, Nasdaq, S&P 500 open higher as investors focus on cooling inflation data, Trump Media merger update
18 Dec 2025 16:47 GMT
… the US economy.
Trump Media merger update
On Thursday, Trump Media … ), according to MarketWatch data.
Athira Pharma Inc., Paranovus Entertainment Technology Ltd … Inc, Werewolf Therapeutics Inc, Processa Pharmaceuticals Inc, Inno Holdings Inc., Mega …
-
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
18 Dec 2025 12:50 GMT
… (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) … Therapeutics. “With the merger complete, we are now … strategic collaborations with big pharma, technology leaders, and … projected. Contact:
Salarius Pharmaceuticals
Rick Pierce, CEO
Pierce …
About
© 1995-2025